We are live on !
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Summit Therapeutics
SMMT
$12.4B
| $223K | 0.07% |
+15,312
| New | +$272K |
2026 Q2
0 quarters
|
|
202
People Inc
PPLI
$2.86B
| $220K | 0.07% |
+4,763
| New | +$203K |
2026 Q2
0 quarters
|
|
203
ESCO Technologies
ESE
$6.51B
| $218K | 0.07% |
+624
| New | +$195K |
2026 Q2
0 quarters
|
|
204
Sutro Biopharma
STRO
$187M
| $218K | 0.07% |
6,569
-842
| -11% | -$26.3K |
2026 Q1
1 quarter
|
|
205
CALL
Kodiak Sciences
KOD
$5.74B
| $216K | 0.06% |
502
+501
| +50,100% | +$19.5K |
2025 Q3
3 quarters
|
|
206
FTAI Aviation
FTAI
$16.8B
| $214K | 0.06% |
+792
| New | +$199K |
2026 Q2
0 quarters
|
|
207
Bombardier Recreational Products
DOO
$3.89B
| $214K | 0.06% |
+3,505
| New | +$211K |
2026 Q2
0 quarters
|
|
|
DMRA
208
Damora Therapeutics
DMRA
$1.19B
| $210K | 0.06% |
8,084
+2,746
| +51% | +$66.5K |
2026 Q1
1 quarter
|
|
209
Zai Lab
ZLAB
$2.7B
| $210K | 0.06% |
11,040
-1,299
| -11% | -$25.7K |
2025 Q4
2 quarters
|
|
210
CALL
Annexon
ANNX
$760M
| $207K | 0.06% |
897
| – | – |
2025 Q4
2 quarters
|
|
|
DPC
211
DPC Holdings PLC
DPC
$4.78B
| $206K | 0.06% |
+4,200
| New | +$205K |
2026 Q2
0 quarters
|
|
212
Alto Neuroscience
ANRO
$896M
| $203K | 0.06% |
+7,698
| New | +$178K |
2026 Q2
0 quarters
|
|
213
Etsy
ETSY
$7.83B
| $201K | 0.06% |
+2,673
| New | +$172K |
2026 Q2
0 quarters
|
|
214
Maze Therapeutics
MAZE
$1.65B
| $200K | 0.06% |
6,709
-2,059
| -23% | -$54K |
2025 Q4
2 quarters
|
|
215
CoreWeave
CRWV
$33.7B
| $199K | 0.06% |
2,000
-892
| -31% | -$96.3K |
2026 Q1
1 quarter
|
|
216
ON Semiconductor
ON
$28.5B
| $199K | 0.06% |
+2,100
| New | +$215K |
2026 Q2
0 quarters
|
|
217
enGene Therapeutics
ENGN
$106M
| $198K | 0.06% |
+114,493
| New | +$467K |
2026 Q2
0 quarters
|
|
218
Crescent Biopharma
CBIO
$459M
| $197K | 0.06% |
+10,968
| New | +$214K |
2026 Q2
0 quarters
|
|
219
Starz Entertainment Corp
STRZ
$390M
| $196K | 0.06% |
+6,805
| New | +$148K |
2026 Q2
0 quarters
|
|
220
PUT
Novo Nordisk
NVO
$170B
| $196K | 0.06% |
143
| – | – |
2025 Q3
3 quarters
|
|
221
Assembly Biosciences
ASMB
$410M
| $191K | 0.06% |
+6,942
| New | +$189K |
2026 Q2
0 quarters
|
|
222
Ecolab
ECL
$80.2B
| $188K | 0.06% |
+676
| New | +$178K |
2026 Q2
0 quarters
|
|
223
Live Nation Entertainment
LYV
$39.8B
| $188K | 0.06% |
+1,026
| New | +$169K |
2026 Q2
0 quarters
|
|
224
CALL
EyePoint Inc
EYPT
$37.9M
| $186K | 0.06% |
269
| – | – |
2026 Q1
1 quarter
|
|
225
CALL
Hims & Hers Health
HIMS
$6.57B
| $185K | 0.06% |
+510
| New | +$13.7K |
2026 Q2
0 quarters
|
|
Similar funds
JWM
PI
TFA
SIM
OWM
SS
BIA
TODC
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.